Biotech Special Committee of Seer’s Board of Directors Unanimously Rejects Unsolicited Acquisition Proposal from Omid Farokhzad, M.D. July 20, 2026
Biotech 4DMT Announces Positive 2-Year Data from PRISM Phase 2b Clinical Trial in a Broad Wet AMD Population July 19, 2026
Biotech REGENXBIO Presents Positive Long-Term Data for Surabgene Lomparvovec in Wet AMD and Diabetic Retinopathy at American Society of Retina Specialists Annual Meeting July 19, 2026
Biotech DBV Technologies Files At-The-Market (ATM) Prospectus for Up to $150 Million of Sales July 18, 2026
Biotech Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) July 18, 2026
Biotech Clearmind Medicine Reports Positive Retention Results for Intranasal Formulation of its Psychedelic-Based Neuroplastogen MEAI July 16, 2026
Biotech Cosmos Health Share Buyback Surpasses $1 Million, Reaching 4.84 Million Shares; Continues Open Market Repurchases July 16, 2026
Biotech Cumulus Neuroscience Presents Data at AAIC 2026 Annual Meeting Showing a Two-Minute Digital Task Matches or Outperforms Clinical Benchmarks for Alzheimer’s Trial Pre-enrichment July 15, 2026
Biotech ALZHEIMER’S BLOOD TEST COULD BRING HIGHLY ACCURATE DIAGNOSIS INTO EVERYDAY CLINICAL CARE July 14, 2026